Digestive EndoscopyA new low-volume isosmotic polyethylene glycol solution plus bisacodyl versus split-dose 4 L polyethylene glycol for bowel cleansing prior to colonoscopy: A randomised controlled trial
Introduction
Colorectal cancer (CRC) is the second most common cancer as well as the second leading cause of cancer-related mortality in Europe [1]. Screening and early detection of adults >50 years old have reduced the incidence and mortality over the last 15 years. Colonoscopy, the gold standard for detection of early signs of CRC, was fundamental in achieving this important success against this cancer [2]. Bowel preparation is an important quality measure for colonoscopy. Inadequate bowel cleansing may have negative consequences for the examination, including incomplete visualisation of the colon, missed detection of lesions, procedural difficulties, prolonged procedure time and reduced interval time for follow-up with significant economic impact [3]. The ideal preparation should completely and rapidly empty the colon of any material (solid, liquid, gaseous) without any effect on the gross or microscopic appearance of the colon, not cause significant shifts of fluids or electrolytes and be well tolerated and accepted by the patient [4].
Polyethylene glycol (PEG) osmotically balanced electrolyte solutions pass through the bowel without significant absorption or secretion. These preparations are therefore a safe option in patients with serum electrolyte imbalance, acute and chronic renal insufficiency and congestive heart failure [5], [6] PEG is usually administered as a 4 L solution in order to achieve a satisfactory level of cleansing. However this large volume has been shown to reduce the tolerability and compliance of the bowel preparation [7]. Indeed, patient surveys have identified that the most critical step of the whole colonoscopy procedure is the large volume of liquid which needs to be ingested. This therefore creates a barrier to removing fear from patients and obtaining complete adhesion to screening campaigns. To overcome this limitation, low-volume preparations have been proposed. A new isosmotic low-volume sulphate-free PEG 2 L preparation with citrates and simethicone (PEG-CS) is now available to be used in combination with bisacodyl to improve tolerability, acceptability and compliance. The primary aim of our trial was to compare 2 L PEG-CS + bisacodyl tablets given either the same day or the day before with split-dose 4 L PEG in outpatients undergoing elective colonoscopy, in terms of cleansing level.
Section snippets
Patients and methods
This is a randomised, observer-blind, parallel 3-arm, active control study including consecutive outpatients undergoing routine elective colonoscopy at the Digestive Endoscopy Unit of the Catholic University of Rome. The study protocol and informed consent form were approved by the Institutional Review Board. Outpatients aged 18–85 years undergoing routine elective colonoscopy and providing written informed consent were eligible for participation in the study. Exclusion criteria were as
Results
A total of 153 patients were randomly allocated to treatments. Two patients (both in the 4 L PEG group) did not complete the study because of non-compliance and consent withdrawn (Fig. 1). The three groups were comparable for age, sex, and BMI, for clinical indications as well as performance of colonoscopy (Table 2). There were no significant differences in the proportion of patients having morning vs afternoon colonoscopy in the 3 treatment groups.
In both 2-L PEG-CS + bisacodyl groups, 3 tablets
Discussion
According to the results of this study, a new low-volume PEG-based bowel preparation plus bisacodyl tablets was at least as effective as the split-dose 4 L PEG in achieving an adequate level of bowel cleansing but was better tolerated and accepted. The same day regimen of the new combined bowel preparation had a higher rate of “excellent” bowel preparation than split-dose 4 L PEG. Both low-volume PEG regimens had better mucosal visualisation scores (i.e. less bubbles and foam obscuring the
Conflict of interest statement
The study was supported by Promefarm, Milano, Italy. Data were independently analysed by the investigators. Paola Cesaro and Guido Costamagna received a research grant from Promefarm. The other authors disclosed no financial relationship relevant to this publication.
References (22)
- et al.
Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study
Gastrointestinal Endoscopy
(2005) - et al.
A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)
Gastrointestinal Endoscopy
(2006) - et al.
Bowel preparation before colonoscopy in the era of mass screening for colo-rectal cancer: a practical approach
Digestive and Liver Disease
(2009) - et al.
Validation of a new scale for the assessment of bowel preparation quality
Gastrointestinal Endoscopy
(2004) - et al.
Effective bowel cleansing before colonoscopy: a randomized study of split-dosage versus non-split dosage regimens of high-volume versus low-volume polyethylene glycol solutions
Gastrointestinal Endoscopy
(2010) Split dosing of bowel preparations for colonoscopy: an analysis of its efficacy, safety, and tolerability
Gastrointestinal Endoscopy
(2010)Bowel preparation for colonoscopy: shortening the runway time
Gastrointestinal Endoscopy
(2009)- et al.
Acute phosphate nephropathy
Kidney International
(2009) - et al.
Progress in colorectal cancer survival in Europe from the late 1980 to the early 21st century: the EUROCARE study
International Journal of Cancer
(2012) - et al.
American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]
American Journal of Gastroenterology
(2009)
Bowel preparations for colonoscopy: a review
American Journal of Health-System Pharmacy
Cited by (39)
The Bowel CLEANsing National Initiative: High-Volume Split-Dose Vs Low-Volume Split-Dose Polyethylene Glycol Preparations: A Randomized Controlled Trial
2022, Clinical Gastroenterology and HepatologyDimethyl silicone dry nanoemulsion inhalations: Formulation study and anti-acute lung injury effect
2015, International Journal of PharmaceuticsSplit-Dose Preparations Are Superior to Day-Before Bowel Cleansing Regimens: A Meta-analysis
2015, GastroenterologyCitation Excerpt :Thirteen trials (4083 patients) compared PEG split-dose vs PEG day-before preparations.31,32,34,35,39,41,42,51,52,54,55,59,67 Ten studies with analyzable data31,32,34,39,41,42,51,52,55,59 showed that the administration of PEG split-dose regimens yielded significantly greater proportions of patients with adequate preparations (OR, 2.60; 1.46;4.63). Six trials (1609 patients) were included in the comparison of NaP split-dose with day-before NaP intake.
Bowel preparation for colonoscopy. Any significant progress on the horizon?
2015, Gastroenterologia y Hepatologia